 BEDMER, N.J., April 06, 2022 GLOBE NEWSWIRE -- Matinas BioPharma NYSE AMER: MTNB, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal LNC platform technology, announced today that Jerry Jabbour, Chief Executive Officer, has been invited to present at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, 2022, at 3:00 p.m. ET. 